Rising costs for prescriptions and hospital services were felt in latest PCE report, though health inflation has been mild in the past year.
The health policy reform is part of the Democrats' Inflation Reduction Act, which could aid 48 million Medicare recipients.
It's an effort to compete with drugstore chains and pharmacy startups.
The plan would empower the Department of Health and Human Services to negotiate lower prices.
The answer comes down to one key tactic: negotiation.
President Trump expected to address the summit Wednesday.
The idea is that transparency would lead to more competition and lower costs. One drug company is already on board.
Contaminated supply chains, natural disasters, and the bottom line are just some of the reasons why basic drugs are in constant shortage.
President Trump is expected to call for an end to HIV transmission by 2030. The drug known as PrEP may be key.
Drug companies can get creative with doctor incentives, and that can be problematic.